Molecular Alterations in Pediatric Fibroblastic/Myofibroblastic Tumors: An Appraisal of a Next Generation Sequencing Assay in a Retrospective Single Centre Study
- 10 May 2021
- journal article
- research article
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 24 (5) , 405-421
Abstract
Background: Pediatric fibroblastic/myofibroblastic tumors (PFMTs) can be challenging to definitively classify. Large case series or diagnostic updates have not been recently published despite identification of molecular alterations that could improve diagnostic accuracy. Our review of the literature found that over two-thirds of the more than 30 types of PFMTs harbor recurrent molecular alterations. We performed an institutional review of PFMTs to highlight limitations of a predominantly morphological classification, and evaluated the utility of a next-generation sequencing assay to aid diagnosis. Methods: PFMTs identified over a period of 12 years were reviewed, categorized per the new WHO classification, and tested using the Oncomine Childhood Cancer Research Assay. Results: Eighty-seven specimens from 58 patients were reviewed; 50 were chosen for molecular analysis, 16 (32%) lacking definitive classification. We identified alterations, some novel, in 33% of assayed cases. Expected alterations were identified for most known diagnoses and mutations were identified in 6 of 16 tumors (38%) that were initially unclassified. Conclusion: We confirmed a significant subset of PFMTs remain difficult to classify using current criteria, and that a combined DNA/RNA assay can identify alterations in many of these cases, improving diagnostic certainty and suggesting a clinical utility for challenging cases.Keywords
Funding Information
- Alberta Children’s Hospital Research Institute and the University of Calgary Anatomical Pathology Residency Program
This publication has 94 references indexed in Scilit:
- FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastomaLaboratory Investigation, 2012
- Fibroblastic and Myofibroblastic Tumors in Children and AdolescentsPediatric and Developmental Pathology, 2012
- Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumorGenes, Chromosomes and Cancer, 2011
- DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic HybridisationPLOS ONE, 2010
- Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysisLaboratory Investigation, 2010
- Loss of the PTCH1 gene locus in cardiac fibromaCardiovascular Pathology, 2008
- Gardner-Associated Fibromas (GAF) in Young PatientsAmerican Journal of Surgical Pathology, 2001
- Recurrent chromosome changes in two adult fibrosarcomasGenes, Chromosomes and Cancer, 1998
- Fibroblastic-Myofibroblastic Tumors in Children and Adolescents: A Clinicopathologic Study of 108 Examples in 103 PatientsPediatric Pathology, 1991
- Cytogenetic analysis of a plexiform fibrohistiocytic tumorCancer Genetics and Cytogenetics, 1990